title: Leptin: a potential anxiolytic by facilitation of fear extinction.
abstract: OBJECTIVE
  Anxiety disorders are characterized by a deficient extinction of fear memory. Evidence is growing that leptin influences numerous neuronal functions. The aims of this study were to investigate the effects and the mechanism of leptin on fear extinction.
  
  
  RESULTS
  Leptin (1 mg/kg, i.p) was applied to evaluate the anxiolytic effect in rat behavioral tests. Field potentials recording were used to investigate the changes in synaptic transmission in the thalamic-lateral amygadala (LA) pathway of rat. We found that leptin produced strong anxiolytic effects under basal condition and after acute stress. Systemic administration and intra-LA infusions of leptin facilitated extinction of conditioned fear responses. The antagonist of NMDA receptor, MK-801, blocked the effect of leptin on fear extinction completely. Furthermore, these effects of leptin on fear extinction were accompanied by a reversal of conditioning-induced synaptic potentiation in the LA. Leptin facilitated NMDA receptor-mediated synaptic transmission, and reversed amygdala long-term potentiation (LTP) in a dose-dependent manner in vitro, and this LTP depotentiation effect was mediated by NMDA receptor and MAPK signaling pathway.
  
  
  CONCLUSIONS
  These results identify a key role of leptin in dampening fear conditioning-induced synaptic potentiation in the LA through NMDA receptor and indicate a new strategy for treating anxiety disorders.
authors: Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
authors: Wei
authors: W
authors: Wang
authors: Song-Lin
authors: SL
authors: Liu
authors: Kuan
authors: K
authors: Li
authors: Yu
authors: Y
authors: Chen
authors: Bo
authors: B
authors: Jiang
authors: Yan-Kun
authors: YK
authors: Li
authors: Jun-Li
authors: JL
authors: Xiao
authors: Si
authors: S
authors: Yang
authors: Tao
authors: T
authors: Chen
authors: Jian-Guo
authors: JG
authors: Chen
authors: Jia-Geng
authors: JG
authors: Li
authors: Fang
authors: F
authors: Wang
mesh_terms: D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D001007:Anxiety / Q000188:drug therapy* / Q000503:physiopathology; D066272:Basolateral Nuclear Complex / Q000187:drug effects / Q000503:physiopathology; D003213:Conditioning, Psychological / Q000187:drug effects / Q000502:physiology; D016291:Dizocilpine Maleate / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D005108:Extinction, Psychological / Q000187:drug effects* / Q000502:physiology; D005239:Fear / Q000187:drug effects* / Q000502:physiology; D020738:Leptin / Q000494:pharmacology*; D017774:Long-Term Potentiation / Q000187:drug effects / Q000502:physiology; D008810:Mice, Inbred C57BL; D009434:Neural Pathways / Q000187:drug effects / Q000503:physiopathology; D011897:Random Allocation; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors / Q000378:metabolism; D011994:Recombinant Proteins / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology; D013788:Thalamus / Q000187:drug effects / Q000503:physiopathology; D046509:Tissue Culture Techniques
chemical_list: D014151:Anti-Anxiety Agents; D018691:Excitatory Amino Acid Antagonists; D020738:Leptin; D016194:Receptors, N-Methyl-D-Aspartate; D011994:Recombinant Proteins; D016291:Dizocilpine Maleate
keywords: Amygdala; Anxiety; Fear conditioning; Leptin; Long-term potentiation
references: Endocrinology. 1999 Dec;140(12):5995-8
references: 10579368
references: Brain Res. 2000 Jun 23;868(2):251-8
references: 10854577
references: J Neurosci. 2001 Dec 15;21(24):RC186
references: 11734601
references: Mol Pharmacol. 2003 Jan;63(1):44-52
references: 12488535
references: J Neurosci. 2003 Sep 10;23(23):8410-6
references: 12968003
references: J Neurosci. 1992 Mar;12(3):854-63
references: 1347562
references: Psychosom Med. 2004 Jan-Feb;66(1):23-8
references: 14747634
references: Science. 2004 Apr 2;304(5667):110-5
references: 15064421
references: Learn Mem. 2005 Mar-Apr;12(2):130-7
references: 15774944
references: J Neurochem. 2005 Oct;95(2):396-405
references: 16086687
references: J Neurosci. 2005 Sep 21;25(38):8725-34
references: 16177042
references: J Neurosci. 2005 Oct 26;25(43):10010-4
references: 16251449
references: Peptides. 2006 Jun;27(6):1420-5
references: 16293343
references: J Affect Disord. 2006 Jan;90(1):21-7
references: 16324751
references: Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1593-8
references: 16423896
references: Prog Lipid Res. 2006 Sep;45(5):369-78
references: 16678906
references: Peptides. 2006 Nov;27(11):2738-49
references: 16914228
references: Biol Psychiatry. 2006 Aug 15;60(4):322-8
references: 16919522
references: Neuron. 2006 Sep 21;51(6):811-22
references: 16982425
references: Mol Psychiatry. 2007 Feb;12(2):120-50
references: 17160066
references: Mt Sinai J Med. 2006 Nov;73(7):941-9
references: 17195879
references: Stroke. 2007 Aug;38(8):2329-36
references: 17600230
references: Clin Psychol Rev. 2008 Mar;28(3):366-86
references: 17707562
references: Nature. 2007 Aug 23;448(7156):894-900
references: 17713528
references: Curr Opin Pharmacol. 2007 Dec;7(6):643-7
references: 18024215
references: Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20955-60
references: 18165656
references: Recent Pat CNS Drug Discov. 2008 Nov;3(3):166-78
references: 18991806
references: J Neurochem. 2009 Feb;108(3):685-96
references: 19054283
references: Science. 2009 May 15;324(5929):951-5
references: 19342552
references: Neuroimmunomodulation. 2010;17(1):39-46
references: 19816056
references: Psychopharmacology (Berl). 2010 Jan;207(4):535-45
references: 19823809
references: PLoS One. 2009 Oct 26;4(10):e7548
references: 19855841
references: Eur J Neurosci. 2009 Dec 3;30(11):2089-99
references: 20128847
references: Psychopharmacology (Berl). 2010 Jul;210(4):559-68
references: 20422404
references: Science. 2010 Nov 19;330(6007):1108-12
references: 21030604
references: Br J Pharmacol. 2011 Mar;162(6):1364-79
references: 21133890
references: Mol Psychiatry. 2011 Oct;16(10):1024-38
references: 21483433
references: Behav Neurosci. 1996 Jun;110(3):618-20
references: 8889007
references: J Biol Chem. 1997 Jun 13;272(24):15057-60
references: 9182522
references: Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):7001-5
references: 9192681
references: Nature. 1997 Dec 11;390(6660):607-11
references: 9403689